News

Revolve publishes a paper in Scientific Reports on the development of mRhubarb719 and mRhubarb720, new infrared fluorescent proteins with improved brightness and red-shifting for enhanced in vivo imaging of tissues!


Revolve is selected as a Finalist for the 2018 Maryland Incubator Company of the Year!


Dr. Firnberg to present at GTCbio Novel Protein Therapeutics in Baltimore, Maryland


Revolve Biotechnologies will be at SynBioBeta San Francisco 2015 - come visit our Exhibit Booth to learn more about us!


Revolve Biotechnologies Awarded $450K Phase I SBIR to develop IR fluorescent proteins for deep brain imaging.


TEDCO's Maryland Innovation Initiative awards Revolve a Phase III grant for $100,000.


Revolve will be at the TEDCO 4th Annual Entrepreneur Expo on Nov. 12


Revolve will be at PepTalk 2015 in San Diego, CA, Jan. 19-20. Come to our BuzZ session on library construction!


Revolve is accepted to the NSF DC I-Corp Accelerator Program


Revolve is looking to hire a Protein Engineer/Molecular Biology Scientist!


Revolve will be at Next Generation Protein Therapeutics Summit in SF - June 4-6. Come see our poster presentation and say hello!


Revolve will be at PEGS Boston 2014 - May 5-6.


Paper published in Molecular Biology and Evolution presenting a comprehensive, high-resolution gene fitness landscape using Revolve technology.


Presto! Mutated Gene Libraries - Revolve featured in Johns Hopkins Engineering Winter 2014.


Revolve profiled in JHU's Fast Forward News.


Dr. Marc Ostermeier and the Revolve team is awarded a $100K phase I grant by the Maryland Innovation Initiative.


Paper published in Nucleic Acids Research using Revolve technology to demonstrate the limitations and benefits of the genetic code on protein evolution and how to circumvent these limitations in the lab.


The Revolve team reaches the finals of JHU Business Plan Competition (Top 8 of 18 teams).